- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02439021
Effectiveness of the New Perilaryngeal Airway in Comparison With the Laryngeal Mask Airway
May 5, 2015 updated by: Amir H Pakpour, Qazvin University Of Medical Sciences
Effectiveness of the New Perilaryngeal Airway (CobraPLA™) in Comparison With the Laryngeal Mask Airway (LMA™) to Improve Oropharyngeal Leak Pressure Among Obese and Overweight Patients
The Laryngeal Mask Airway (LMA) has been used widely for different patients and found to be highly safe for adult and pediatric patients.
However, the LMA has some limitations and weaknesses (e.g. more insertion attempts in 5% to 10 % of all cases.
Despite the easy insertion of the LMA, it is crucial to check correct placement of the LMA airway.
Study Overview
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 25 to 35 kg/m2
- scheduled for surgery
- being older than 18 years
- Mallampati class I-III and BMI between 25 and 35
Exclusion Criteria:
- pregnancy
- morbid obese (BMI>35 kg/m2)
- a known difficult airway
- gastro-oesophageal reflux
- pharyngeal pathology
- emergency operation with full stomach
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CobraPLA
Patients will randomly assign to either LMA or Cobra PLATM
|
|
|
Experimental: LMA
Patients will randomly assign to either LMA or Cobra PLATM
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oropharyngeal leak
Time Frame: Up to 1 hours
|
Up to 1 hours
|
|
|
Time to intubation
Time Frame: Up to 1 hours
|
Time to intubation was measured from inserting of the device to the patient's month while connecting the breathing circuit
|
Up to 1 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
successful intubation attempt
Time Frame: Up to 1 hours
|
A successful intubation attempt was recognized if: the breathing circuit connected, the EtCO2 trace was revealed, and no air leak was detected at airway pressures of 15 cm H2O
|
Up to 1 hours
|
|
incidence of sore throat
Time Frame: Up to 1 hours
|
Up to 1 hours
|
|
|
incidence of dysphasia
Time Frame: Up to 1 hours
|
Up to 1 hours
|
|
|
incidence of postoperative blood staining on mask
Time Frame: Up to 1 hours
|
Up to 1 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Amir H Pakpour, PhD, Qazvin University of Medical Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
January 1, 2013
Study Registration Dates
First Submitted
February 5, 2015
First Submitted That Met QC Criteria
May 5, 2015
First Posted (Estimate)
May 8, 2015
Study Record Updates
Last Update Posted (Estimate)
May 8, 2015
Last Update Submitted That Met QC Criteria
May 5, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 653
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on COBRA
-
CeloNova BioSciences, Inc.CompletedCoronary Artery DiseaseUnited States, Spain, Serbia, France, Switzerland, Germany, Latvia
-
University of VirginiaNot yet recruitingHealthy | Ankle Sprain | Chronic Ankle Instability, CAIUnited States
-
Endoscopic Technologies, IncTerminatedPersistent Atrial FibrillationUnited States
-
CeloNova BioSciences, Inc.AlpinARCCompletedMyocardial Infarction | Stable Angina | Unstable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary SyndromeFrance
-
CeloNova BioSciences, Inc.UnknownAngina, Stable | Angina, Unstable | AnticoagulantsUnited States, Denmark, France, Germany, Belgium, Italy, Latvia, Switzerland
-
University of California, IrvineCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingCancer | Metastatic Cancer | Primary CancerUnited States
-
Abbott Medical OpticsCompletedStudy Focus is Healthy Contact Lens WearersUnited States
-
Medlogics Device CorporationStanford University; Baim Institute for Clinical ResearchUnknownCoronary Artery DiseaseIsrael, United Kingdom, Netherlands, Germany
-
Nova Southeastern UniversityCompletedOcular Conditions Resulting in Visual ImpairmentUnited States